Published in Inflamm Bowel Dis on August 30, 2010
Imaging of intact tissue sections: moving beyond the microscope. J Biol Chem (2011) 1.60
Investigating the biological and clinical significance of human dysbioses. Trends Microbiol (2011) 1.48
Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl Res (2012) 1.29
MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. Trends Biotechnol (2011) 1.15
MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice. Lab Invest (2015) 1.12
Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol (2013) 1.07
Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis (2011) 0.95
Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives. World J Gastroenterol (2015) 0.95
Comprehensive identification of proteins from MALDI imaging. Mol Cell Proteomics (2013) 0.95
Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies. World J Gastroenterol (2014) 0.93
Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Proteomics Clin Appl (2013) 0.92
Systems medicine: evolution of systems biology from bench to bedside. Wiley Interdiscip Rev Syst Biol Med (2015) 0.83
Current application of proteomics in biomarker discovery for inflammatory bowel disease. World J Gastrointest Pathophysiol (2016) 0.81
A pilot study of transrectal endoscopic ultrasound elastography in inflammatory bowel disease. BMC Gastroenterol (2011) 0.81
Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. Clin Med Insights Gastroenterol (2015) 0.81
Serum Proteome Profiles in Stricturing Crohn's Disease: A Pilot Study. Inflamm Bowel Dis (2015) 0.80
Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World J Gastrointest Surg (2014) 0.76
Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis. World J Gastrointest Endosc (2015) 0.76
Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.76
Update on current applications of proteomic in the study of inflammatory bowel disease. Ann Gastroenterol (2012) 0.75
Changes in protein expression after treatment with Ancylostoma caninum excretory/secretory products in a mouse model of colitis. Sci Rep (2017) 0.75
Proteome analysis of the macroscopically affected colonic mucosa of Crohn's disease and intestinal tuberculosis. Sci Rep (2016) 0.75
Quantitative Proteomics of Gut-Derived Th1 and Th1/Th17 Clones Reveal the Presence of CD28+ NKG2D- Th1 Cytotoxic CD4+ T cells. Mol Cell Proteomics (2015) 0.75
Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PLoS One (2017) 0.75
The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol (2017) 0.75
Inflammatory bowel disease. N Engl J Med (2002) 21.17
Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet (2003) 4.01
HIGH DIMENSIONAL VARIABLE SELECTION. Ann Stat (2009) 3.72
Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity (2002) 3.46
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut (2005) 3.31
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol (2007) 2.39
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics (2006) 2.03
Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J Mol Diagn (2006) 1.89
Integrating histology and imaging mass spectrometry. Anal Chem (2004) 1.86
Profiling and imaging proteins in tissue sections by MS. Anal Chem (2004) 1.45
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res (2010) 1.43
Serologic markers in inflammatory bowel disease. Clin Chem (2005) 1.40
Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med (2009) 1.36
Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. Am J Gastroenterol (2005) 1.34
Colo-rectal biopsy in inflammatory bowel disease. Monogr Pathol (1977) 1.17
Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease. J Proteome Res (2007) 1.13
Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochem Pharmacol (2006) 1.10
How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop. J Clin Pathol (2002) 1.05
Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis? J Clin Pathol (2006) 0.96
Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clin Biochem (2008) 0.95
Inflammatory bowel disease and environmental influences. Gastroenterol Clin North Am (2002) 0.95
Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it? World J Gastroenterol (2009) 0.94
Risk factors for pouch failure in patients with different phenotypes of Crohn's disease of the pouch. Inflamm Bowel Dis (2008) 0.92
Proteomics and chronic inflammatory bowel diseases. Pathol Res Pract (2004) 0.90
Raised plasma concentrations of platelet factor 4 (PF4) in Crohn's disease. Gut (1987) 0.87
Genomics and proteomics approaches to the study of cancer-stroma interactions. BMC Med Genomics (2010) 0.87
Crohn's disease of the ileal pouch: reality, diagnosis, and management. Inflamm Bowel Dis (2009) 0.85
The final diagnosis in pouch patients for presumed ulcerative colitis may change to Crohn's disease: patients should be warned of the consequences. Acta Chir Iugosl (2000) 0.85
Depth of ulceration in acute colitis: correlation with outcome and clinical and radiologic features. Gastroenterology (1980) 0.85
Adhesion molecules in chronic ulcerative colitis. Int J Colorectal Dis (2006) 0.85
Inflammatory bowel disease-associated gene expression in intestinal epithelial cells by differential cDNA screening and mRNA display. Inflamm Bowel Dis (2003) 0.85
Crohn's disease in the ileal pouch after total colectomy for ulcerative colitis: findings on pouch enemas in six patients. AJR Am J Roentgenol (2005) 0.83
Genetic and pathogenetic insights into inflammatory bowel disease. Curr Gastroenterol Rep (2003) 0.83
Depth of colorectal biopsies with proctoscopic forceps. Gastrointest Endosc (1987) 0.78
A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med (2011) 6.40
Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods (2005) 6.23
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med (2004) 6.02
Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med (2002) 6.00
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron (2005) 4.78
Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med (2002) 4.66
Metal chelation and inhibition of bacterial growth in tissue abscesses. Science (2008) 4.55
Toll-like receptors in the pathogenesis of human disease. Nat Immunol (2004) 4.40
Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med (2005) 4.25
The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med (2005) 4.25
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Methods (2007) 4.20
Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet (2003) 4.01
Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med (2002) 4.00
The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell (2012) 3.91
Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A (2005) 3.52
In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest (2008) 3.35
Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med (2006) 3.32
Genetic analysis of complex traits in the emerging Collaborative Cross. Genome Res (2011) 3.25
Protection from experimental asthma by an endogenous bronchodilator. Science (2005) 3.17
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet (2013) 3.17
Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. Anal Chem (2006) 3.03
Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. J Mass Spectrom (2003) 2.84
Automated acoustic matrix deposition for MALDI sample preparation. Anal Chem (2006) 2.83
Allergen-induced airway disease is mouse strain dependent. Am J Physiol Lung Cell Mol Physiol (2003) 2.56
The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med (2003) 2.44
The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med (2004) 2.43
Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res (2004) 2.41
Molecular imaging of proteins in tissues by mass spectrometry. Proc Natl Acad Sci U S A (2008) 2.38
New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. J Proteome Res (2006) 2.33
Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development (2005) 2.31
MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med (2013) 2.31
Exposures to the Kuwait oil fires and their association with asthma and bronchitis among gulf war veterans. Environ Health Perspect (2002) 2.24
Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat Methods (2008) 2.24
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA (2013) 2.20
Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. J Mass Spectrom (2007) 2.20
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 2.17
Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest (2003) 2.16
Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom (2003) 2.15
MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue. Anal Chem (2008) 2.09
Concern TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation. Am J Respir Crit Care Med (2009) 2.07
Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res (2005) 2.06
A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics (2006) 2.03
The pathophysiology of asthma. Annu Rev Med (2002) 1.98
The acute respiratory distress syndrome. Ann Intern Med (2004) 1.96
Enhancement of protein sensitivity for MALDI imaging mass spectrometry after chemical treatment of tissue sections. J Am Soc Mass Spectrom (2008) 1.96
High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics (2008) 1.91
High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med (2005) 1.90
Integrating histology and imaging mass spectrometry. Anal Chem (2004) 1.86
Solvent-free matrix dry-coating for MALDI imaging of phospholipids. J Am Soc Mass Spectrom (2008) 1.86
Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest (2003) 1.85
Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics (2004) 1.82
Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. Chem Rev (2013) 1.80
Specificity and complexity of the Caenorhabditis elegans innate immune response. Mol Cell Biol (2007) 1.78
The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. PLoS One (2013) 1.78
Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax (2013) 1.77
Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am J Pathol (2004) 1.76
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2002) 1.76
Processing MALDI Mass Spectra to Improve Mass Spectral Direct Tissue Analysis. Int J Mass Spectrom (2007) 1.73
Molecular imaging by mass spectrometry--looking beyond classical histology. Nat Rev Cancer (2010) 1.72
Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J (2005) 1.72
Epigenetic mechanisms and the development of asthma. J Allergy Clin Immunol (2012) 1.67
Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal carcinoma. Gastrointest Endosc (2006) 1.67
MALDI-MS-based imaging of small molecules and proteins in tissues. Curr Opin Chem Biol (2006) 1.66
Tissue profiling by mass spectrometry: a review of methodology and applications. Mol Cell Proteomics (2005) 1.64
Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.63
Three-dimensional visualization of protein expression in mouse brain structures using imaging mass spectrometry. J Am Soc Mass Spectrom (2005) 1.62
Imaging of intact tissue sections: moving beyond the microscope. J Biol Chem (2011) 1.60
Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest (2005) 1.60
Mass spectrometric profiling of intact biological tissue by using desorption electrospray ionization. Angew Chem Int Ed Engl (2005) 1.59
The pros and cons of peptide-centric proteomics. Nat Biotechnol (2010) 1.58
Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis. Cancer Biol Ther (2002) 1.58
Monitoring the inflammatory response to infection through the integration of MALDI IMS and MRI. Cell Host Microbe (2012) 1.58
Integrating spatially resolved three-dimensional MALDI IMS with in vivo magnetic resonance imaging. Nat Methods (2007) 1.58
Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation. J Lipid Res (2009) 1.58
Gulf War veterans with anxiety: prevalence, comorbidity, and risk factors. Epidemiology (2004) 1.57
Direct imaging of single cells and tissue at sub-cellular spatial resolution using transmission geometry MALDI MS. J Mass Spectrom (2012) 1.57
Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS One (2009) 1.56
Profiling and imaging of tissues by imaging ion mobility-mass spectrometry. J Mass Spectrom (2007) 1.55
Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice. J Biol Chem (2009) 1.55
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med (2014) 1.54
Imaging mass spectrometry: principles and potentials. Toxicol Pathol (2005) 1.54
Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res (2004) 1.53
Matrix sublimation/recrystallization for imaging proteins by mass spectrometry at high spatial resolution. Anal Chem (2011) 1.52
Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. Am J Respir Cell Mol Biol (2008) 1.51
Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values. Bioinformatics (2012) 1.49
The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am J Respir Crit Care Med (2004) 1.48
Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration. PLoS Pathog (2012) 1.47
Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol (2002) 1.47
Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am J Physiol Lung Cell Mol Physiol (2008) 1.46
Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology (2010) 1.45
TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer. Clin Cancer Res (2008) 1.44
Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol (2005) 1.44
Retracted Nitric oxide mediates relative airway hyporesponsiveness to lipopolysaccharide in surfactant protein A-deficient mice. Am J Respir Cell Mol Biol (2010) 1.44
Assessing protein patterns in disease using imaging mass spectrometry. J Proteome Res (2004) 1.44
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res (2010) 1.43